{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:06:51Z","timestamp":1792858011305,"version":"4.5.0"},"reference-count":340,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/X010511\/1"],"award-info":[{"award-number":["MR\/X010511\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.pharmthera.2026.108995","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:15:54Z","timestamp":1770164154000},"page":"108995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Therapeutic interventions for coronary microvascular obstruction after acute myocardial infarction: Developments and challenges"],"prefix":"10.1016","volume":"282","author":[{"given":"Alessandro","family":"Maino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Leo","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Portolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafail","family":"Kotronias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Ameri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Vergallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Italo","family":"Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Crea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Banning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Tammaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Luigi","family":"De Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/MCA.0000000000000423","article-title":"Efficacy and safety of intracoronary verapamil versus sodium nitroprusside for the prevention of microvascular obstruction during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction","volume":"28","author":"Abdelaziz","year":"2017","journal-title":"Coronary Artery Disease"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb0010","first-page":"E009536","article-title":"Sonothrombolysis improves myocardial dynamics and microvascular obstruction preventing left ventricular remodeling in patients with ST elevation myocardial infarction","volume":"13","author":"Aguiar","year":"2020","journal-title":"Circulation: Cardiovascular Imaging"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0015","doi-asserted-by":"crossref","DOI":"10.1007\/s00392-025-02734-0","article-title":"Impact of oral nicorandil administration prior to primary percutaneous coronary intervention on no-reflow: a randomized controlled trial","author":"Ahmed","year":"2025","journal-title":"Clinical Research in Cardiology: Official Journal of the German Cardiac Society"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108995_bb0020","first-page":"793","article-title":"Combination of the thermodilution-derived index of microcirculatory resistance and coronary flow reserve is highly predictive of microvascular obstruction on cardiac magnetic resonance imaging after ST-segment elevation myocardial infarction","volume":"9","author":"Ahn","year":"2016","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb0025","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00005344-199510000-00006","article-title":"Vasodilatory effect of nicorandil on coronary arterial microvessels: Its dependency on vessel size and the involvement of the ATP-sensitive potassium channels","volume":"26","author":"Akai","year":"1995","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0030","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34861","article-title":"Capillary pericytes express \u03b1-smooth muscle actin, which requires prevention of filamentous-actin depolymerization for detection","volume":"7","author":"Alarcon-Martinez","year":"2018","journal-title":"ELife"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.108995_bb0035","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1161\/CIRCULATIONAHA.123.064155","article-title":"Cardiac pericytes acquire a fibrogenic phenotype and contribute to vascular maturation after myocardial infarction","volume":"148","author":"Alex","year":"2023","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb0040","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cmet.2018.02.016","article-title":"The pericyte of the pancreatic islet regulates capillary diameter and local blood flow","volume":"27","author":"Alma\u00e7a","year":"2018","journal-title":"Cell Metabolism"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014214","article-title":"In vitro and in vivo preclinical testing of pericyte-engineered grafts for the correction of congenital heart defects","volume":"9","author":"Alvino","year":"2020","journal-title":"Journal of the American Heart Association"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108995_bb0050","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/ccd.23278","article-title":"Incidence, predictors, and prognostic value of intramyocardial hemorrhage lesions in ST elevation myocardial infarction","volume":"79","author":"Amabile","year":"2012","journal-title":"Catheterization and Cardiovascular Interventions"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/heartjnl-2013-303832","article-title":"Invasive measurement of coronary microvascular resistance in patients with acute myocardial infarction treated by primary PCI","volume":"100","author":"Amier","year":"2014","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108995_bb0060","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005651","article-title":"Predictors of intramyocardial hemorrhage after reperfused ST-segment elevation myocardial infarction","volume":"6","author":"Amier","year":"2017","journal-title":"Journal of the American Heart Association"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2006.05.010","article-title":"Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial","volume":"152","author":"Amit","year":"2006","journal-title":"American Heart Journal"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108995_bb0070","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.3390\/jcm11082233","article-title":"\u201cNo-Reflow\u201d phenomenon: A contemporary review","volume":"11","author":"Annibali","year":"2022","journal-title":"Journal of Clinical Medicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.108995_bb0075","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.jacc.2003.07.017","article-title":"A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction","volume":"42","author":"Antoniucci","year":"2003","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/ccd.31665","article-title":"Effect of intracoronary tirofiban through guiding catheter compared with intracoronary tirofiban through aspiration catheter on the microvascular obstruction in patients with STEMI undergoing PCI: A cardiac MR study","author":"Asfour","year":"2025","journal-title":"Catheterization and Cardiovascular Interventions."},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108995_bb0085","article-title":"Erythropoietin protects cardiomyocytes from cell death during hypoxia\/reperfusion injury through activation of survival signaling pathways","volume":"9","author":"Asiya Parvin","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb0090","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/0271678X15610340","article-title":"What is a pericyte?","volume":"36","author":"Attwell","year":"2016","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0095","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1160\/TH13-02-0166","article-title":"Persistent enhanced platelet activation in patients with acute myocardial infarction and coronary microvascular obstruction: Clinical implications","volume":"111","author":"Aurigemma","year":"2013","journal-title":"Thrombosis and Haemostasis"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41569-023-00913-y","article-title":"The role of cardiac pericytes in health and disease: therapeutic targets for myocardial infarction","volume":"21","author":"Avolio","year":"2024","journal-title":"Nature Reviews. Cardiology"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108995_bb0105","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152308","article-title":"Cardiac pericyte reprogramming by MEK inhibition promotes arteriologenesis and angiogenesis of the ischemic heart","volume":"132","author":"Avolio","year":"2022","journal-title":"The Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb0110","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002043","article-title":"Expansion and characterization of neonatal cardiac pericytes provides a novel cellular option for tissue engineering in congenital heart disease","volume":"4","author":"Avolio","year":"2015","journal-title":"Journal of the American Heart Association"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb0115","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/jmri.24431","article-title":"MRI demonstrates a decrease in myocardial infarct healing and increase in compensatory ventricular hypertrophy following mechanical microvascular obstruction","volume":"40","author":"Bajwa","year":"2014","journal-title":"Journal of Magnetic Resonance Imaging"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-017-1166-z","article-title":"In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvasculature","volume":"15","author":"Baranyai","year":"2017","journal-title":"Journal of Translational Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb0125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/00129784-200303040-00004","article-title":"Hyperoxemic perfusion for treatment of reperfusion microvascular ischemia in patients with myocardial infarction","volume":"3","author":"Bartorelli","year":"2003","journal-title":"American Journal of Cardiovascular Drugs\u00a0: Drugs, Devices, and Other Interventions"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10554-009-9499-1","article-title":"Intramyocardial hemorrhage and microvascular obstruction after primary percutaneous coronary intervention","volume":"26","author":"Beek","year":"2010","journal-title":"International Journal of Cardiovascular Imaging"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0135","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000231721","article-title":"The basement membrane of intramyocardial capillaries is thickened in patients with acute myocardial infarction","volume":"47","author":"Begieneman","year":"2009","journal-title":"Journal of Vascular Research"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.108995_bb0140","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1007\/s00330-010-1849-9","article-title":"Clinical implications of microvascular obstruction and intramyocardial haemorrhage in acute myocardial infarction using cardiovascular magnetic resonance imaging","volume":"20","author":"Bekkers","year":"2010","journal-title":"European Radiology"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.108995_bb0145","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.jacc.2009.12.037","article-title":"Microvascular obstruction: underlying pathophysiology and clinical diagnosis","volume":"55","author":"Bekkers","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bib1631","article-title":"Comparison of immediate with delayed stenting using the minimalist immediate mechanical intervention approach in acute ST-Segment-Elevation myocardial infarction: The MIMI study","volume":"9","author":"Belle","year":"2016","journal-title":"Circulation: Cardiovascular Interventions"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2022.104802","article-title":"The temporal impact of erythropoietin administration on mitochondrial function and dynamics in cardiac ischemia\/reperfusion injury","volume":"127","author":"Benjanuwattra","year":"2022","journal-title":"Experimental and Molecular Pathology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb0155","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/cvr\/cvp033","article-title":"Loss of cardioprotection with ageing","volume":"83","author":"Boengler","year":"2009","journal-title":"Cardiovascular Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb0160","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/CIRCRESAHA.117.311678","article-title":"New initiatives to improve the rigor and reproducibility of articles published in circulation research","volume":"121","author":"Bolli","year":"2017","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-021-00874-8","article-title":"CAESAR\u2019s legacy: a new era of rigor in preclinical studies of cardioprotection","volume":"116","author":"Bolli","year":"2021","journal-title":"Basic Research in Cardiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb0170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1161\/01.RES.0000137171.97172.d7","article-title":"Myocardial protection at a crossroads: The need for translation into clinical therapy","volume":"95","author":"Bolli","year":"2004","journal-title":"Circulation Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108995_bb0175","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1182\/blood.V99.8.2794","article-title":"Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque","volume":"99","author":"Bonderman","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb0180","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-018-0696-8","article-title":"Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection","volume":"113","author":"B\u00f8tker","year":"2018","journal-title":"Basic Research in Cardiology"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.108995_bb0185","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0190","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1152\/ajpregu.00165.2017","article-title":"Highs and lows of hyperoxia: physiological, performance, and clinical aspects","volume":"315","author":"Brugniaux","year":"2018","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb0195","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.carpath.2005.03.006","article-title":"Myocardial ischemia and reperfusion injury","volume":"14","author":"Buja","year":"2005","journal-title":"Cardiovascular Pathology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCULATIONAHA.124.068938","article-title":"Effect of cangrelor on infarct size in ST-segment-elevation myocardial infarction treated by primary percutaneous coronary intervention: a randomized controlled trial (the PITRI trial)","volume":"150","author":"Bulluck","year":"2024","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108995_bb0205","article-title":"Residual myocardial iron following intramyocardial hemorrhage during the convalescent phase of reperfused ST-segment-elevation myocardial infarction and adverse left ventricular remodeling","volume":"9","author":"Bulluck","year":"2016","journal-title":"Circulation: Cardiovascular Imaging"},{"issue":"38","key":"10.1016\/j.pharmthera.2026.108995_bb0210","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"European Heart Journal"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108995_bb0215","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1073\/pnas.0630444100","article-title":"Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling","volume":"100","author":"Calvillo","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb0220","first-page":"595","article-title":"Basics of coronary thermodilution","volume":"14","author":"Candreva","year":"2021","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"20","key":"10.1016\/j.pharmthera.2026.108995_bib1628","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.jacc.2014.02.530","article-title":"A randomized trial of deferred stenting versus immediate stenting to prevent No- or slow-reflow in acute ST-Segment elevation myocardial infarction (DEFER-STEMI)","volume":"63","author":"Carrick","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0225","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ahj.2024.12.009","article-title":"Transcoronary cooling and dilution for cardioprotection during revascularisation for ST-segment elevation myocardial infarction: Design and rationale of the STEMI-Cool study","volume":"282","author":"Carulli","year":"2025","journal-title":"American Heart Journal"},{"issue":"S1","key":"10.1016\/j.pharmthera.2026.108995_bb0230","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/jth.12952","article-title":"P2Y12 receptors: Structure and function","volume":"13","author":"Cattaneo","year":"2015","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108995_bb0235","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1093\/cvr\/cvad008","article-title":"The longevity-associated BPIFB4 gene supports cardiac function and vascularization in ageing cardiomyopathy","volume":"119","author":"Cattaneo","year":"2023","journal-title":"Cardiovascular Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb0240","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/ccd.29090","article-title":"One-year outcomes of supersaturated oxygen therapy in acute anterior myocardial infarction: The IC-HOT study","volume":"97","author":"Chen","year":"2021","journal-title":"Catheterization and Cardiovascular Interventions"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-33776-x","article-title":"Intramyocardial hemorrhage drives fatty degeneration of infarcted myocardium","volume":"13","author":"Cokic","year":"2022","journal-title":"Nature Communications"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108995_bb0250","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003642","article-title":"Iron-sensitive cardiac magnetic resonance imaging for prediction of ventricular arrhythmia risk in patients with chronic myocardial infarction: Early evidence","volume":"8","author":"Cokic","year":"2015","journal-title":"Circulation Cardiovascular Imaging"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.108995_bb0255","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.029279","article-title":"Partial mural cell ablation disrupts coronary vasculature integrity and induces systolic dysfunction","volume":"12","author":"Cornuault","year":"2023","journal-title":"Journal of the American Heart Association"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108995_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3003368","article-title":"Ending publication bias: A values-based approach to surface null and negative results","volume":"23","author":"Curry","year":"2025","journal-title":"PLoS Biology"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.108995_bb0265","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1111\/bph.12856","article-title":"Experimental design and analysis and their reporting: New guidance for publication in BJP","volume":"172","author":"Curtis","year":"2015","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0270","first-page":"51","article-title":"Effect of endovascular cooling on myocardial temperature, infarct size, and cardiac output in human-sized pigs","volume":"282(5","author":"Dae","year":"2002","journal-title":"American Journal of Physiology - Heart and Circulatory Physiology"},{"issue":"18","key":"10.1016\/j.pharmthera.2026.108995_bb0275","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1093\/cvr\/cvae147","article-title":"Pericytes in the brain and heart: functional roles and response to ischaemia and reperfusion","volume":"120","author":"Dalkara","year":"2025","journal-title":"Cardiovascular Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb0280","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/ther.2020.0018","article-title":"Cooling as an adjunctive therapy to percutaneous intervention in acute myocardial infarction: COOL-MI InCor trial","volume":"11","author":"Dallan","year":"2021","journal-title":"Therapeutic Hypothermia and Temperature Management"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108995_bb0285","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1161\/ATV.0000000000000062","article-title":"Recommendation on design, execution, and reporting of animal atherosclerosis studies: A scientific statement from the American Heart Association","volume":"37","author":"Daugherty","year":"2017","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb0290","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/ccd.27905","article-title":"Evaluation of intracoronary hyperoxemic oxygen therapy in acute anterior myocardial infarction: The IC-HOT study","volume":"93","author":"David","year":"2019","journal-title":"Catheterization and Cardiovascular Interventions"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0295","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2018.09.086","article-title":"Multitarget strategies to reduce myocardial ischemia\/reperfusion injury: JACC review topic of the week","volume":"73","author":"Davidson","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb0300","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/01.CIR.73.3.418","article-title":"Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death","volume":"73","author":"Davies","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.856747","article-title":"Adenosine in acute myocardial infarction-associated reperfusion injury: Does it still have a role?","volume":"13","author":"De Marco","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb0310","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.4244\/EIJ-D-18-00378","volume":"14","author":"De Maria","year":"2018","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb0315","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/joic.12380","article-title":"Role of deferred stenting in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention: A systematic review and meta-analysis","volume":"30","author":"De Maria","year":"2017","journal-title":"Journal of Interventional Cardiology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108995_bb0320","doi-asserted-by":"crossref","first-page":"935","DOI":"10.4244\/EIJ-D-17-00367","volume":"13","author":"De Maria","year":"2017","journal-title":"EuroIntervention"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb0325","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jcmg.2018.02.018","article-title":"Index of microcirculatory resistance as a tool to characterize microvascular obstruction and to predict infarct size regression in patients with STEMI undergoing primary PCI","volume":"12","author":"De Maria","year":"2019","journal-title":"JACC. Cardiovascular Imaging"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108995_bb0330","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.4244\/EIJV12I10A202","article-title":"A tool for predicting the outcome of reperfusion in ST-elevation myocardial infarction using age, thrombotic burden and index of microcirculatory resistance (ATI score)","volume":"12","author":"De Maria","year":"2016","journal-title":"EuroIntervention"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb0335","article-title":"Pressure-controlled intermittent coronary sinus occlusion (PiCSO) in acute myocardial infarction: The PiCSO-AMI-I trial","volume":"17","author":"De Maria","year":"2024","journal-title":"Circulation: Cardiovascular Interventions"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.108995_bb0340","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1136\/heartjnl-2016-309642","article-title":"Reconsidering the back door approach by targeting the coronary sinus in ischaemic heart disease","volume":"102","author":"De Maria","year":"2016","journal-title":"Heart"},{"issue":"47","key":"10.1016\/j.pharmthera.2026.108995_bb0345","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1093\/eurheartj\/ehx414","article-title":"Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials","volume":"38","author":"De Waha","year":"2017","journal-title":"European Heart Journal"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100052","article-title":"The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player","volume":"77","author":"Divecha","year":"2025","journal-title":"Pharmacological Reviews"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.108995_bb0355","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/S0735-1097(02)02567-6","article-title":"Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction","volume":"40","author":"Dixon","year":"2002","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb0360","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.jcbfm.9600272","article-title":"CNS microvascular pericytes exhibit multipotential stem cell activity","volume":"26","author":"Dore-Duffy","year":"2006","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0365","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijcard.2015.03.359","article-title":"Novel insights into an \u201cold\u201d phenomenon: the no reflow","volume":"187","author":"Durante","year":"2015","journal-title":"International Journal of Cardiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb0370","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005841","article-title":"Identification of High-Risk Patients after ST-Segment-Elevation Myocardial Infarction. Circulation","volume":"10","author":"Durante","year":"2017","journal-title":"Cardiovascular Imaging"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.108995_bb0375","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.jacc.2024.02.052","article-title":"Prognostic value of microvascular resistance reserve after percutaneous coronary intervention in patients with myocardial infarction","volume":"83","author":"Eerdekens","year":"2024","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcha.2020.100526","article-title":"Effect of Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) on infarct size in anterior STEMI: PiCSO in ACS study","volume":"28","author":"Egred","year":"2020","journal-title":"IJC Heart and Vasculature"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01738-3","article-title":"Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1","volume":"8","author":"Eilken","year":"2017","journal-title":"Nature Communications"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb0390","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCIMAGING.110.960500","article-title":"Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation- myocardial infarction","volume":"4","author":"Eitel","year":"2011","journal-title":"Circulation Cardiovascular Imaging"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb0395","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ahj.2010.02.019","article-title":"Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging","volume":"159","author":"Eitel","year":"2010","journal-title":"American Heart Journal"},{"issue":"47","key":"10.1016\/j.pharmthera.2026.108995_bb0400","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1093\/eurheartj\/ehae587","article-title":"Glycoprotein IIb\/IIIa inhibitors in acute myocardial infarction and angiographic microvascular obstruction: the REVERSE-FLOW trial","volume":"45","author":"Eitel","year":"2024","journal-title":"European Heart Journal"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.108995_bb0405","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.jacc.2013.01.048","article-title":"Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: Cardiac magnetic resonance substudy of the AIDA STEMI trial","volume":"61","author":"Eitel","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"5\u20136","key":"10.1016\/j.pharmthera.2026.108995_bb0410","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s12265-017-9768-7","article-title":"Effect of intracoronary and intravenous melatonin on myocardial salvage index in patients with ST-elevation myocardial infarction: a randomized placebo controlled trial","volume":"10","author":"Ekeloef","year":"2017","journal-title":"Journal of Cardiovascular Translational Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108995_bb0415","first-page":"E010326","article-title":"Hypothermia for reduction of myocardial reperfusion injury in acute myocardial infarction: Closing the translational gap","volume":"14","author":"El Farissi","year":"2021","journal-title":"Circulation: Cardiovascular Interventions"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.108995_bb0420","first-page":"2383","article-title":"The index of microcirculatory resistance after primary PCI: A pooled analysis of individual patient data","volume":"16","author":"El Farissi","year":"2023","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb0425","first-page":"345","article-title":"Contrast ultrasound, sonothrombolysis and sonoperfusion in cardiovascular disease: Shifting to theragnostic clinical trials","volume":"15","author":"El Kadi","year":"2022","journal-title":"JACC: Cardiovascular Imaging"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108995_bb0430","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.echo.2024.06.018","article-title":"Sonothrombolysis in patients with ST-elevation myocardial infarction with electrocardiographic no-reflow after percutaneous coronary intervention: A randomized controlled trial","volume":"37","author":"El Kadi","year":"2024","journal-title":"Journal of the American Society of Echocardiography"},{"issue":"2 (20\/2)","key":"10.1016\/j.pharmthera.2026.108995_bb0435","article-title":"Role of leukocytes in response to acute myocardial ischemia and reflow in dogs","volume":"251","author":"Engler","year":"1986","journal-title":"American Journal of Physiology - Heart and Circulatory Physiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0440","first-page":"98","article-title":"Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog","volume":"111","author":"Engler","year":"1983","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0445","author":"Enhancing Reproducibility through Rigor and Transparency | Grants & Funding"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb0450","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/ther.2015.0009","article-title":"Therapeutic hypothermia for the treatment of acute myocardial infarction-combined analysis of the RAPID MI-ICE and the CHILL-MI trials","volume":"5","author":"Erlinge","year":"2015","journal-title":"Therapeutic Hypothermia and Temperature Management"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.108995_bb0455","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005409","article-title":"Index of microcirculatory resistance at the time of primary percutaneous coronary intervention predicts early cardiac complications: Insights from the OxAMI (oxford study in acute myocardial infarction) cohort","volume":"6","author":"Fahrni","year":"2017","journal-title":"Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2026.108995_bb0460","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1016\/j.ihj.2018.01.032","article-title":"The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: A meta-analysis","volume":"70","author":"Fajar","year":"2018","journal-title":"Indian Heart Journal"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb0465","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.CIR.71.4.699","article-title":"Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and\/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion","volume":"71","author":"Falk","year":"1985","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.108995_bib1627","doi-asserted-by":"crossref","first-page":"e740","DOI":"10.4244\/EIJ-D-23-01042","article-title":"A randomised trial of selective intracoronary hypothermia during primary PCI","volume":"20","author":"Farissi","year":"2024","journal-title":"EuroIntervention"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108995_bb0470","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.036632","article-title":"Apolipoprotein E deficiency accelerates atherosclerosis development in miniature pigs","volume":"11","author":"Fang","year":"2018","journal-title":"Disease Models & Mechanisms"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.108995_bb0475","article-title":"Invasive assessment of the coronary microvasculature: The index of microcirculatory resistance","volume":"10","author":"Fearon","year":"2017","journal-title":"Circulation: Cardiovascular Interventions"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb0480","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1124\/pr.113.008300","article-title":"Interaction of risk factors, comorbidities, and comedications with ischemia\/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning","volume":"66","author":"Ferdinandy","year":"2014","journal-title":"Pharmacological Reviews"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb0485","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/CIRCRESAHA.117.310901","article-title":"Effect of ischemia duration and protective interventions on the temporal dynamics of tissue composition after myocardial infarction","volume":"121","author":"Fern\u00e1ndez-Jim\u00e9nez","year":"2017","journal-title":"Circulation Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bib1617","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s10554-020-02142-7","article-title":"Prognostic value and clinical predictors of intramyocardial hemorrhage measured by CMR T2* sequences in STEMI","volume":"37","author":"Ferr\u00e9-Vallverd\u00fa","year":"2021","journal-title":"The International Journal of Cardiovascular Imaging"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.108995_bb0490","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s40265-013-0126-z","article-title":"Pharmacology of the new P2Y12 receptor inhibitors: Insights on pharmacokinetic and pharmacodynamic properties","volume":"73","author":"Ferri","year":"2013","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb0495","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrcardio.2017.18","article-title":"Antithrombotic therapy for patients with STEMI undergoing primary PCI","volume":"14","author":"Franchi","year":"2017","journal-title":"Nature Reviews Cardiology"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.108995_bb0500","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.jacc.2009.08.024","article-title":"Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction. Insight from cardiovascular magnetic resonance","volume":"54","author":"Francone","year":"2009","journal-title":"Journal of the American College of Cardiology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108995_bb0505","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14204","article-title":"The fate and role of the pericytes in myocardial diseases","volume":"54","author":"Frangogiannis","year":"2024","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0510","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.74211","article-title":"Pericyte-mediated constriction of renal capillaries evokes no-reflow and kidney injury following ischaemia","volume":"11","author":"Freitas","year":"2022","journal-title":"ELife"},{"issue":"17","key":"10.1016\/j.pharmthera.2026.108995_bb0515","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1308789","article-title":"Thrombus aspiration during ST-segment elevation myocardial infarction","volume":"369","author":"Fr\u00f6bert","year":"2013","journal-title":"The New England Journal of Medicine"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.108995_bb0520","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/eurheartj\/eht090","article-title":"Myocardial reperfusion injury: Looking beyond primary PCI","volume":"34","author":"Fr\u00f6hlich","year":"2013","journal-title":"European Heart Journal"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bib1619","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1067\/mnc.2000.107273","article-title":"Nicorandil affords cardioprotection in patients with acute myocardial infarction treated with primary percutaneous transluminal coronary angiosplasty: Assessment with thallium-201\/iodine-123 BMIPP dual SPECT","volume":"7","author":"Fukuzawa","year":"2000","journal-title":"Journal of Nuclear Cardiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb0525","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1055\/s-2005-869521","article-title":"The platelet P2 receptors in thrombosis","volume":"31","author":"Gachet","year":"2005","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb0530","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41569-023-00953-4","article-title":"Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction","volume":"21","author":"Galli","year":"2024","journal-title":"Nature Reviews. Cardiology"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.108995_bb0535","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/eurheartj\/ehp093","article-title":"Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction","volume":"30","author":"Ganame","year":"2009","journal-title":"European Heart Journal"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb0540","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00135.2009","article-title":"Both \u03b21- and \u03b22-adrenoceptors contribute to feedforward coronary resistance vessel dilation during exercise","volume":"298","author":"Gao","year":"2010","journal-title":"American Journal of Physiology - Heart and Circulatory Physiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0545","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-021-02301-1","article-title":"Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials","volume":"21","author":"Geng","year":"2021","journal-title":"BMC Cardiovascular Disorders"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.108995_bb0550","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1161\/01.CIR.101.23.2734","article-title":"Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction","volume":"101","author":"Gerber","year":"2000","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108995_bb0555","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jama.293.8.979","article-title":"Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: Is the slope of the curve the shape of the future?","volume":"293","author":"Gersh","year":"2005","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.pharmthera.2026.108995_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12185934","article-title":"Microvascular obstruction in acute myocardial infarction, a potential therapeutic target","volume":"12","author":"Ghobrial","year":"2023","journal-title":"Journal of Clinical Medicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.108995_bb0565","first-page":"1366","article-title":"Cardiac magnetic resonance evaluation of LV remodeling post-myocardial infarction: Prognosis, monitoring and trial endpoints","volume":"17","author":"Gissler","year":"2024","journal-title":"JACC: Cardiovascular Imaging"},{"issue":"43","key":"10.1016\/j.pharmthera.2026.108995_bb0570","doi-asserted-by":"crossref","first-page":"27022","DOI":"10.1073\/pnas.1922755117","article-title":"Contractile pericytes determine the direction of blood flow at capillary junctions","volume":"117","author":"Gonzales","year":"2020","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb0575","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1152\/jappl.2000.89.5.1903","article-title":"Quantitative analysis of feedforward sympathetic coronary vasodilation in exercising dogs","volume":"89","author":"Gorman","year":"2000","journal-title":"Journal of Applied Physiology"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0580","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2261-8-7","article-title":"Rapid short-duration hypothermia with cold saline and endovascular cooling before reperfusion reduces microvascular obstruction and myocardial infarct size","volume":"8","author":"G\u00f6tberg","year":"2008","journal-title":"BMC Cardiovascular Disorders"},{"issue":"10029","key":"10.1016\/j.pharmthera.2026.108995_bb0585","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials","volume":"387","author":"Goyal","year":"2016","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb0590","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005426","article-title":"Cardioprotective effects of intracoronary morphine in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a prospective, randomized trial","volume":"6","author":"Gwag","year":"2017","journal-title":"Journal of the American Heart Association"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb0595","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00788947","article-title":"Regional hypothermia reduces myocardial necrosis even when instituted after the onset of ischemia","volume":"92","author":"Hale","year":"1997","journal-title":"Basic Research in Cardiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0600","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature13165","article-title":"Capillary pericytes regulate cerebral blood flow in health and disease","volume":"508","author":"Hall","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0605","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/761415","article-title":"Porcine models of accelerated coronary atherosclerosis: role of diabetes mellitus and hypercholesterolemia","volume":"2013","author":"Hamamdzic","year":"2013","journal-title":"Journal of Diabetes Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108995_bib1616","first-page":"940","article-title":"Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: A systematic review and meta-analysis","volume":"7","author":"Hamirani","year":"2014","journal-title":"JACC: Cardiovascular Imaging"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.108995_bb0610","first-page":"935","article-title":"Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations","volume":"38","author":"Hausenloy","year":"2017","journal-title":"European Heart Journal"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb0615","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cvr\/cvx049","article-title":"Novel targets and future strategies for acute cardioprotection: Position paper of the european society of cardiology working group on cellular biology of the heart","volume":"113","author":"Hausenloy","year":"2017","journal-title":"Cardiovascular Research"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.108995_bb0620","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.jacc.2019.03.020","article-title":"Translating cardioprotection for patient benefit: The EU-cardioprotection cost action","volume":"73","author":"Hausenloy","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb0625","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1253\/circj.72.327","article-title":"Intracoronary nicorandil relieves multiple coronary vasospasm with hemodynamic collapse","volume":"72","author":"Hayashi","year":"2008","journal-title":"Circulation Journal"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb0630","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0735-1097(94)90010-8","article-title":"Angioscopic versus angiographic detection of initial detection of intimal dissection and intracoronary thrombus","volume":"24","author":"den Heijer","year":"1994","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-009-0074-7","article-title":"Editorial: Adenosine and maximum coronary vasodilation in humans: Myth and misconceptions in the assessment of coronary reserve","volume":"105","author":"Heusch","year":"2010","journal-title":"Basic Research in Cardiology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108995_bb0640","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.117.310820","article-title":"Critical issues for the translation of cardioprotection","volume":"120","author":"Heusch","year":"2017","journal-title":"Circulation Research"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.108995_bb0645","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia\u2013reperfusion injury and cardioprotection in perspective","volume":"17","author":"Heusch","year":"2020","journal-title":"Nature Reviews Cardiology"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0650","doi-asserted-by":"crossref","DOI":"10.1177\/10742484231179613","article-title":"Cardioprotection and its translation: A need for new paradigms? Or for New Pragmatism? An opinionated retro- and perspective","volume":"28","author":"Heusch","year":"2023","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.108995_bb0655","first-page":"774","article-title":"The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: A continual challenge","volume":"38","author":"Heusch","year":"2017","journal-title":"European Heart Journal"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb0660","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/CIRCULATIONAHA.119.044176","article-title":"Is cardioprotection salvageable?","volume":"141","author":"Heusch","year":"2020","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108995_bb0665","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/CIRCRESAHA.118.313947","article-title":"Translation, translation, translation: The need for large animal studies in cardioprotection research","volume":"123","author":"Heusch","year":"2018","journal-title":"Circulation Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb0670","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0735-1097(01)01138-X","article-title":"Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: Initial human clinical experience","volume":"37","author":"Hillegass","year":"2001","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.108995_bb0675","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1177\/0271678X221111598","article-title":"Hyperoxia evokes pericyte-mediated capillary constriction","volume":"42","author":"Hirunpattarasilp","year":"2022","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108995_bb0680","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157233","article-title":"Dissecting the effects of ischemia and reperfusion on the coronary microcirculation in a rat model of acute myocardial infarction","volume":"11","author":"Hollander","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0685","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ahj.2021.11.005","article-title":"Intravenous nicorandil during primary percutaneous coronary intervention in patients with ST-Elevation myocardial infarction: Rationale and design of the Clinical Efficacy and Safety of Intravenous Nicorandil (CLEAN) trial","volume":"244","author":"Huang","year":"2022","journal-title":"American Heart Journal"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0690","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2011.09.083","article-title":"Predictors of cardiovascular magnetic resonance-derived microvascular obstruction on patient admission in STEMI","volume":"166","author":"Husser","year":"2013","journal-title":"International Journal of Cardiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb0695","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.ijcard.2012.05.055","article-title":"Cardiovascular magnetic resonance-derived intramyocardial hemorrhage after STEMI: Influence on long-term prognosis, adverse left ventricular remodeling and relationship with microvascular obstruction","volume":"167","author":"Husser","year":"2013","journal-title":"International Journal of Cardiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb0700","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jacc.2019.05.024","article-title":"Cardiac MRI endpoints in myocardial infarction experimental and clinical trials: JACC scientific expert panel","volume":"74","author":"Ibanez","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.108995_bb0705","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.jacc.2015.02.032","article-title":"Evolving therapies for myocardial ischemia\/reperfusion injury","volume":"65","author":"Ib\u00e1\u00f1ez","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb0710","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"39","author":"Ibanez","year":"2018","journal-title":"European Heart Journal"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.108995_bb0715","first-page":"1082","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"70","author":"Ib\u00e1nez","year":"2017","journal-title":"Revista Espanola de Cardiologia (English Ed.)"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108995_bib1620","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/CIRCULATIONAHA.104.530329","article-title":"Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction","volume":"112","author":"Ishii","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb0720","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10557-013-6456-y","article-title":"Beneficial effects of intracoronary nicorandil on microvascular dysfunction after primary percutaneous coronary intervention: Demonstration of its superiority to nitroglycerin in a cross-over study","volume":"27","author":"Ito","year":"2013","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.108995_bb0725","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.amjcard.2004.02.030","article-title":"Prediction of the no-reflow phenomenon with ultrasonic tissue characterization in patients with anterior wall acute myocardial infarction","volume":"93","author":"Iwakura","year":"2004","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0730","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1160\/TH10-07-0482","article-title":"Mode of action of P2Y12 antagonists as inhibitors of platelet function","volume":"105","author":"Iy\u00fa","year":"2011","journal-title":"Thrombosis and Haemostasis"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.108995_bib1632","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.cjca.2020.01.019","article-title":"Immediate vs delayed stenting in ST-Elevation myocardial infarction: Rationale and Design of the international PRIMACY bayesian randomized controlled trial","volume":"36","author":"Jolicoeur","year":"2020","journal-title":"Canadian Journal of Cardiology"},{"issue":"35","key":"10.1016\/j.pharmthera.2026.108995_bb0735","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1093\/eurheartj\/ehv296","article-title":"Stroke in the TOTAL trial: A randomized trial of routine thrombectomy vs. percutaneous coronary intervention alone in ST elevation myocardial infarction","volume":"36","author":"Jolly","year":"2015","journal-title":"European Heart Journal"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.108995_bb0740","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJMoa1415098","article-title":"Randomized trial of primary PCI with or without routine manual thrombectomy","volume":"372","author":"Jolly","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"10014","key":"10.1016\/j.pharmthera.2026.108995_bb0745","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(15)00448-1","article-title":"Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial","volume":"387","author":"Jolly","year":"2016","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb0750","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/CIRCULATIONAHA.116.025371","article-title":"Thrombus aspiration in ST-segment-elevation myocardial infarction: An individual patient meta-analysis: thrombectomy trialists collaboration","volume":"135","author":"Jolly","year":"2017","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb0755","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/CIRCRESAHA.116.305462","article-title":"The NHLBI-Sponsored Consortium for preclinicAl assESsment of cARdioprotective Therapies (CAESAR): A new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs","volume":"116","author":"Jones","year":"2015","journal-title":"Circulation Research"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.108995_bb0760","article-title":"Persistent microvascular obstruction after myocardial infarction culminates in the confluence of ferric iron oxide crystals, proinflammatory burden, and adverse remodeling","volume":"9","author":"Kali","year":"2016","journal-title":"Circulation: Cardiovascular Imaging"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0765","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-09776-8","article-title":"Chronic myocardial and coronary arterial effects of intracoronary supersaturated oxygen therapy in swine with normal and ischemic-reperfused myocardium","volume":"12","author":"Kaluza","year":"2022","journal-title":"Scientific Reports"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb0770","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCULATIONAHA.118.038269","article-title":"Unloading the left ventricle before reperfusion in patients with anterior ST-segment-elevation myocardial infarction: A pilot study using the impella CP","volume":"139","author":"Kapur","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0775","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ahj.2022.08.011","article-title":"Primary left ventricular unloading with delayed reperfusion in patients with anterior ST-elevation myocardial infarction: Rationale and design of the STEMI-DTU randomized pivotal trial","volume":"254","author":"Kapur","year":"2022","journal-title":"American Heart Journal"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb0780","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/CIRCULATIONAHA.112.000029","article-title":"Mechanically unloading the left ventricle before coronary reperfusion reduces left ventricular wall stress and myocardial infarct size","volume":"128","author":"Kapur","year":"2013","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb0785","first-page":"204","article-title":"Mechanisms of the \u201cNo-Reflow\u201d phenomenon after acute myocardial infarction: Potential role of pericytes","volume":"8","author":"Kaul","year":"2023","journal-title":"JACC: Basic to Translational Science"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb0790","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1536\/ihj.46.327","article-title":"Histopathological findings of the no-reflow phenomenon following coronary intervention for acute coronary syndrome","volume":"46","author":"Kawano","year":"2005","journal-title":"International Heart Journal"},{"issue":"10034","key":"10.1016\/j.pharmthera.2026.108995_bb0795","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(16)30072-1","article-title":"Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): An open-label, randomised controlled trial","volume":"387","author":"Kelb\u00e6k","year":"2016","journal-title":"The Lancet"},{"issue":"6269","key":"10.1016\/j.pharmthera.2026.108995_bb0800","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1126\/science.aad0084","article-title":"Fetal liver hematopoietic stem cell niches associate with portal vessels","volume":"351","author":"Khan","year":"2016","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb0805","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003403","article-title":"Infarct size following treatment with second-versus third-generation P2Y12 antagonists in patients with multivessel coronary disease at ST-segment elevation myocardial infarction in the CvLPRIT study","volume":"5","author":"Khan","year":"2016","journal-title":"Journal of the American Heart Association"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.108995_bb0810","article-title":"INNOVATION study (impact of immediate stent implantation versus deferred stent implantation on infarct size and microvascular perfusion in patients with ST-segment-elevation myocardial infarction)","volume":"9","author":"Kim","year":"2016","journal-title":"Circulation: Cardiovascular Interventions"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb0815","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1253\/circj.72.716","article-title":"Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions - Experience at a single center","volume":"72","author":"Kirma","year":"2008","journal-title":"Circulation Journal"},{"issue":"9597","key":"10.1016\/j.pharmthera.2026.108995_bib1622","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(07)61634-1","article-title":"Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): Two randomised trials","volume":"370","author":"Kitakaze","year":"2007","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb0820","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00395-024-01083-9","article-title":"The IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): multicenter pig study on the effect of ischemic preconditioning","volume":"119","author":"Kleinbongard","year":"2024","journal-title":"Basic Research in Cardiology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108995_bb0825","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/bph.12902","article-title":"Extracellular signalling molecules in the ischaemic\/reperfused heart - Druggable and translatable for cardioprotection?","volume":"172","author":"Kleinbongard","year":"2015","journal-title":"British Journal of Pharmacology"},{"issue":"3 I","key":"10.1016\/j.pharmthera.2026.108995_bb0830","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/01.CIR.70.3.513","article-title":"The effect of streptokinase on intramyocardial hemorrhage, infarct size, and the no-reflow phenomenon during coronary reperfusion","volume":"70","author":"Kloner","year":"1984","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.108995_bb0835","first-page":"1021","article-title":"Update on cardioprotective strategies for STEMI: Focus on supersaturated oxygen delivery","volume":"6","author":"Kloner","year":"2021","journal-title":"JACC: Basic to Translational Science"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb0840","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1172\/JCI107898","article-title":"The \u2018no reflow\u2019 phenomenon after temporary coronary occlusion in the dog","volume":"54","author":"Kloner","year":"1974","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb0845","doi-asserted-by":"crossref","first-page":"H550","DOI":"10.1152\/ajpheart.00183.2018","article-title":"No-reflow phenomenon in the heart and brain","volume":"315","author":"Kloner","year":"2018","journal-title":"American Journal of Physiology - Heart and Circulatory Physiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb0850","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/01.CIR.62.5.945","article-title":"Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: Which comes first?","volume":"62","author":"Kloner","year":"1980","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.108995_bb0855","doi-asserted-by":"crossref","first-page":"e810","DOI":"10.4244\/EIJ-D-25-00034","article-title":"Impact of intracoronary supersaturated oxygen therapy on microvascular obstruction and infarct size in patients with acute anterior myocardial infarction","volume":"21","author":"K\u00f6nig","year":"2025","journal-title":"EuroIntervention"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108995_bb0860","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154118","article-title":"The Ca2+-gated channel TMEM16A amplifies capillary pericyte contraction and reduces cerebral blood flow after ischemia","volume":"132","author":"Korte","year":"2022","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0865","article-title":"Evaluating acute ischemic myocardial injury with photon-counting computed tomography","author":"Kotronias","year":"2025","journal-title":"JACC: Cardiovascular Imaging."},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108995_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101893","article-title":"Stent-retriever thrombectomy in STEMI with large thrombus burden: The RETRIEVE AMI randomized trial","volume":"4","author":"Kotronias","year":"2025","journal-title":"JACC Advances"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0875","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.RES.19.1.57","article-title":"Blood supply of the myocardium after temporary coronary occlusion","volume":"19","author":"Krug","year":"1966","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cjca.2023.09.020","article-title":"The canadian cardiovascular society classification of acute atherothrombotic myocardial infarction based on stages of tissue injury severity: An expert consensus statement","volume":"40","author":"Kumar","year":"2024","journal-title":"Canadian Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0885","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.yrtph.2016.03.005","article-title":"Animal models of myocardial infarction: Mainstay in clinical translation","volume":"76","author":"Kumar","year":"2016","journal-title":"Regulatory Toxicology and Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb0890","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/ehjcvp\/pvac069","article-title":"Adenosine as adjunctive therapy in acute coronary syndrome: A meta-analysis of randomized controlled trials","volume":"9","author":"Laborante","year":"2023","journal-title":"European Heart Journal - Cardiovascular Pharmacotherapy"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.108995_bb0895","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1405707","article-title":"Outcomes 1 year after thrombus aspiration for myocardial infarction","volume":"371","author":"Lagerqvist","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb0900","first-page":"581","article-title":"Adenosine: Physiology, pharmacology, and clinical applications","volume":"7","author":"Layland","year":"2014","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0905","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-021-00893-5","article-title":"IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action","volume":"116","author":"Lecour","year":"2021","journal-title":"Basic Research in Cardiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb0910","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/cvr\/cvu225","article-title":"ESC working group cellular biology of the heart: Position paper: Improving the preclinical assessment of novel cardioprotective therapies","volume":"104","author":"Lecour","year":"2014","journal-title":"Cardiovascular Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb0915","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/2211-5463.13021","article-title":"Cardiac pericytes function as key vasoactive cells to regulate homeostasis and disease","volume":"11","author":"Lee","year":"2021","journal-title":"FEBS Open Bio"},{"issue":"3\u20134","key":"10.1016\/j.pharmthera.2026.108995_bb0920","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/1074248411414155","article-title":"Development of an NIH Consortium for PreclinicAl AssESsment of CARdioprotective Therapies (CAESAR): A paradigm shift in studies of infarct size limitation","volume":"16","author":"Lefer","year":"2011","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb0925","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/14740338.2019.1617848","article-title":"Cardiovascular events associated with nicorandil administration prior to primary percutaneous coronary intervention in patients with acute ST-segment elevated myocardial infarction: a systematic review and meta-analysis","volume":"18","author":"Li","year":"2019","journal-title":"Expert Opinion on Drug Safety"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2022.104349","article-title":"Ischemia preconditioning alleviates ischemia\/reperfusion injury-induced coronary no-reflow and contraction of microvascular pericytes in rats","volume":"142","author":"Li","year":"2022","journal-title":"Microvascular Research"},{"issue":"52","key":"10.1016\/j.pharmthera.2026.108995_bb0935","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202105348","article-title":"Ischemic microenvironment-responsive therapeutics for cardiovascular diseases","volume":"33","author":"Li","year":"2021","journal-title":"Advanced Materials"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb0940","doi-asserted-by":"crossref","first-page":"H1056","DOI":"10.1152\/ajpheart.00459.2021","article-title":"Guidelines for in vivo mouse models of myocardial infarction","volume":"321","author":"Lindsey","year":"2021","journal-title":"American Journal of Physiology - Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0945","article-title":"Effects of supersaturated oxygen therapy on infarct size and microvascular obstruction following myocardial infarction: A systematic review and meta-analysis","volume":"293","author":"Lingamsetty","year":"2025","journal-title":"American Heart Journal"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.108995_bb0950","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.jacc.2006.08.031","article-title":"Protective effects of erythropoietin in cardiac ischemia. From bench to bedside","volume":"48","author":"Lip\u0161ic","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"issue":"7838","key":"10.1016\/j.pharmthera.2026.108995_bb0955","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","article-title":"Cells of the adult human heart","volume":"588","author":"Litvi\u0148ukov\u00e1","year":"2020","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.108995_bib1629","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.jacc.2017.03.601","article-title":"Myocardial damage in patients with deferred stenting after STEMI: A DANAMI-3\u2013DEFER substudy","volume":"69","author":"L\u00f8nborg","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb0960","doi-asserted-by":"crossref","DOI":"10.1085\/jgp.202313451","article-title":"Electro-metabolic signaling","volume":"156","author":"Longden","year":"2024","journal-title":"The Journal of General Physiology"},{"key":"10.1016\/j.pharmthera.2026.108995_bb0965","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-physiol-031522-034807","article-title":"Pericytes and the control of blood flow in brain and heart","volume":"85","author":"Longden","year":"2023","journal-title":"Annual Review of Physiology"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.108995_bb0970","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1253\/circj.70.1650","article-title":"Nicorandil improves post-ischemic myocardial dysfunction in association with opening the mitochondrial KATP channels and decreasing hydroxyl radicals in isolated rat hearts","volume":"70","author":"Lu","year":"2006","journal-title":"Circulation Journal"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.108995_bb0975","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1136\/hrt.2011.223867","article-title":"Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: A randomised controlled clinical trial","volume":"97","author":"Ludman","year":"2011","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb0980","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s10554-020-01800-0","article-title":"Intracoronary compared with intravenous bolus tirofiban on the microvascular obstruction in patients with STEMI undergoing PCI: a cardiac MR study","volume":"36","author":"Ma","year":"2020","journal-title":"International Journal of Cardiovascular Imaging"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108995_bb0985","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071676","article-title":"Role of neutrophils in cardiac injury and repair following myocardial infarction","volume":"10","author":"Ma","year":"2021","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108995_bb0990","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jamacardio.2024.2298","article-title":"Prehospital pulse-dose glucocorticoid in st-segment elevation myocardial infarction: The PULSE-MI randomized clinical trial","volume":"9","author":"Madsen","year":"2024","journal-title":"JAMA Cardiology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108995_bb0995","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2217\/rme-2016-0121","article-title":"The bone marrow pericyte: An orchestrator of vascular niche","volume":"11","author":"Mangialardi","year":"2016","journal-title":"Regenerative Medicine"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108995_bb1000","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/CIRCRESAHA.116.304944","article-title":"Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size","volume":"116","author":"Mangold","year":"2015","journal-title":"Circulation Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb1005","doi-asserted-by":"crossref","first-page":"216","DOI":"10.15386\/mpr-1261","article-title":"Microvascular obstruction in acute myocardial infarction: An old and unsolved mystery","volume":"92","author":"Marc","year":"2019","journal-title":"Medicine and Pharmacy Reports"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.108995_bb1010","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.amjcard.2015.09.016","article-title":"Myocardial infarct size in patients on long-term statin therapy undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction","volume":"116","author":"Marenzi","year":"2015","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb1015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.CIR.43.1.67","article-title":"Factors influencing infarct size following experimental coronary artery occlusions","volume":"43","author":"Maroko","year":"1971","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bib1630","article-title":"10-Year outcomes of deferred or conventional stent implantation in patients with STEMI (DANAMI-3-DEFER). Circulation","volume":"18","author":"Marquard","year":"2025","journal-title":"Cardiovascular Interventions"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108995_bb1020","doi-asserted-by":"crossref","first-page":"E347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 heart disease and stroke statistics: A report of US and global data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb1025","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/bph.15595","article-title":"Preclinical models of myocardial infarction: from mechanism to translation","volume":"179","author":"Martin","year":"2022","journal-title":"British Journal of Pharmacology"},{"issue":"18","key":"10.1016\/j.pharmthera.2026.108995_bb1030","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.101.18.2154","article-title":"Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction","volume":"101","author":"Marzilli","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.108995_bb1035","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.867070","article-title":"Pericytes\u2019 circadian clock affects endothelial cells\u2019 synchronization and angiogenesis in a 3D tissue engineered scaffold","volume":"13","author":"Mastrullo","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb1040","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1148\/radiol.11110228","article-title":"Timing of cardiovascular MR imaging after acute myocardial infarction: Effect on estimates of infarct characteristics and prediction of late ventricular remodeling","volume":"261","author":"Mather","year":"2011","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb1045","first-page":"453","article-title":"Reperfusion haemorrhage as determined by cardiovascular MRI is a predictor of adverse left ventricular remodelling and markers of late arrhythmic risk","volume":"97","author":"Mather","year":"2011","journal-title":"Heart (British Cardiac Society)"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb1050","first-page":"E012433","article-title":"Sustained mechanical aspiration thrombectomy for high thrombus burden coronary vessel occlusion: The multicenter CHEETAH study","volume":"16","author":"Mathews","year":"2023","journal-title":"Circulation: Cardiovascular Interventions"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.108995_bb1055","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1016\/j.jacc.2019.03.006","article-title":"Sonothrombolysis in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"73","author":"Mathias","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb1060","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/jn\/nxy002","article-title":"The ossabaw pig is a suitable translational model to evaluate dietary patterns and coronary artery disease risk","volume":"148","author":"Matthan","year":"2018","journal-title":"Journal of Nutrition"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb1065","first-page":"1030","article-title":"Evolution of myocardial tissue injury: A CMR study over a decade after STEMI","volume":"15","author":"Mayr","year":"2022","journal-title":"JACC: Cardiovascular Imaging"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108995_bb1070","first-page":"951","article-title":"The potential use of the index of microcirculatory resistance to guide stratification of patients for adjunctive therapy in acute myocardial infarction","volume":"12","author":"Maznyczka","year":"2019","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb1075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2018.19802","article-title":"Effect of low-dose intracoronary alteplase during primary percutaneous coronary intervention on microvascular obstruction in patients with acute myocardial infarction: A randomized clinical trial","volume":"321","author":"McCartney","year":"2019","journal-title":"JAMA - Journal of the American Medical Association"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.108995_bb1080","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jacc.2020.01.041","article-title":"Low-dose alteplase during primary percutaneous coronary intervention according to ischemic time","volume":"75","author":"McCartney","year":"2020","journal-title":"Journal of the American College of Cardiology"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.108995_bb1085","doi-asserted-by":"crossref","first-page":"38891","DOI":"10.1161\/JAHA.124.038891","article-title":"Effects of intracoronary supersaturated oxygen therapy on myocardial blood flow, microvascular obstruction, and myocardial salvage in ST-segment-elevation myocardial infarction in swine ischemia\/reperfusion model","volume":"14","author":"Melo","year":"2025","journal-title":"Journal of the American Heart Association"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb1090","doi-asserted-by":"crossref","first-page":"H1030","DOI":"10.1152\/ajpheart.00312.2021","article-title":"Mechanism and potential treatment of the \u2018no reflow\u2019 phenomenon after acute myocardial infarction: Role of pericytes and GPR39","volume":"231","author":"Methner","year":"2021","journal-title":"American Journal of Physiology - Heart and Circulatory Physiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb1095","first-page":"H255","article-title":"Pericyte constriction underlies capillary derecruitment during hyperemia in the setting of arterial stenosis","volume":"317","author":"Methner","year":"2019"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.108995_bb1100","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.121.056177","article-title":"Effect of colchicine on myocardial injury in acute myocardial infarction","volume":"144","author":"Mewton","year":"2021","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb1105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1089\/ther.2023.0007","article-title":"Efficacy and safety of therapeutic hypothermia as an adjuvant therapy for percutaneous coronary intervention in acute myocardial infarction: A systematic review and meta-analysis","volume":"14","author":"Mir","year":"2024","journal-title":"Therapeutic Hypothermia and Temperature Management"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108995_bb1110","first-page":"1111","article-title":"Prevalence and prognostic significance of lipomatous metaplasia in patients with prior myocardial infarction","volume":"8","author":"Mordi","year":"2015","journal-title":"JACC: Cardiovascular Imaging"},{"issue":"42","key":"10.1016\/j.pharmthera.2026.108995_bb1115","doi-asserted-by":"crossref","first-page":"10052","DOI":"10.1523\/JNEUROSCI.3639-16.2017","article-title":"Disruption of Bmal1 impairs blood-brain barrier integrity via pericyte dysfunction","volume":"37","author":"Nakazato","year":"2017","journal-title":"Journal of Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb1120","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ccd.29113","article-title":"Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no-reflow during primary PCI: The RESTORE observational study","volume":"97","author":"Navarese","year":"2021","journal-title":"Catheterization and Cardiovascular Interventions"},{"issue":"NOV","key":"10.1016\/j.pharmthera.2026.108995_bb1125","article-title":"Immune regulation by pericytes: Modulating innate and adaptive immunity","volume":"7","author":"Navarro","year":"2016","journal-title":"Frontiers in Immunology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108995_bb1130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/eme03090","volume":"3","author":"Nazir","year":"2016","journal-title":"Efficacy and Mechanism Evaluation"},{"issue":"24","key":"10.1016\/j.pharmthera.2026.108995_bb1135","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/eurheartj\/ehw136","article-title":"Strategies to attenuate micro-vascular obstruction during P-PCI: The randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial","volume":"37","author":"Nazir","year":"2016","journal-title":"European Heart Journal"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb1140","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00359.2011","article-title":"Isolation, bulk cultivation, and characterization of coronary microvascular pericytes: The second most frequent myocardial cell type in vitro","volume":"302","author":"Nees","year":"2012","journal-title":"American Journal of Physiology - Heart and Circulatory Physiology"},{"issue":"17","key":"10.1016\/j.pharmthera.2026.108995_bb1145","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/CIRCULATIONAHA.105.603522","article-title":"Invasive assessment of the coronary microcirculation: Superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve","volume":"113","author":"Ng","year":"2006","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb1150","first-page":"580","volume":"6","author":"Niccoli","year":"2013","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.108995_bb1155","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/eurheartj\/ehv484","article-title":"Coronary microvascular obstruction in acute myocardial infarction","volume":"37","author":"Niccoli","year":"2016","journal-title":"European Heart Journal"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb1160","article-title":"Prospective, multicenter, randomized, controlled pilot trial of peritoneal hypothermia in patients with ST-segment - Elevation myocardial infarction","volume":"8","author":"Nichol","year":"2015","journal-title":"Circulation: Cardiovascular Interventions"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bib1625","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.4244\/EIJ-D-17-00279","article-title":"COOL AMI EU pilot trial: A multicentre, prospective, randomised controlled trial to assess cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction","volume":"13","author":"Noc","year":"2017","journal-title":"EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bib1626","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4244\/EIJ-D-21-00348","article-title":"A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction: The COOL AMI EU pivotal trial","volume":"17","author":"Noc","year":"2021","journal-title":"EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology"},{"key":"10.1016\/j.pharmthera.2026.108995_bb1165","article-title":"Capillary pericytes mediate coronary no-reflow after myocardial ischaemia","volume":"6","author":"O\u2019Farrel","year":"2017","journal-title":"ELife"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108995_bb1170","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nrcardio.2014.58","article-title":"A role for pericytes in coronary no-reflow","volume":"11","author":"O\u2019Farrell","year":"2014","journal-title":"Nature Reviews Cardiology"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.108995_bb1175","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1136\/hrt.2010.200634","article-title":"Assessment of severe reperfusion injury with T2* cardiac MRI in patients with acute myocardial infarction","volume":"96","author":"O\u2019Regan","year":"2010","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108995_bb1180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163055","article-title":"Development of accelerated coronary atherosclerosis model using low density lipoprotein receptor knock-out swine with balloon injury","volume":"11","author":"Ogita","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb1185","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0735-1097(00)01171-2","article-title":"Additive effects of nicorandil on coronary blood flow during continuous administration of nitroglycerin","volume":"37","author":"Okamura","year":"2001","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb1190","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.devcel.2011.04.019","article-title":"PDGFR\u03b2 signaling regulates mural cell plasticity and inhibits fat development","volume":"20","author":"Olson","year":"2011","journal-title":"Developmental Cell"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb1195","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ahj.2004.05.014","article-title":"Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Role of inhibitory effect on reactive oxygen species formation","volume":"148","author":"Ono","year":"2004","journal-title":"American Heart Journal"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108995_bib1621","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1253\/circj.70.1099","article-title":"Impact of nicorandil to prevent reperfusion injury in patients with acute myocardial infarction: Sigmart Multicenter Angioplasty Revascularization Trial (SMART)","volume":"70","author":"Ota","year":"2006","journal-title":"Circulation Journal: Official Journal of the Japanese Circulation Society"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb1200","first-page":"558","article-title":"Intracoronary hypothermia for acute myocardial infarction in the isolated beating pig heart","volume":"9","author":"Otterspoor","year":"2017","journal-title":"American Journal of Translational Research"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.108995_bb1205","doi-asserted-by":"crossref","first-page":"e1475","DOI":"10.4244\/EIJ-D-17-00240","article-title":"Safety and feasibility of selective intracoronary hypothermia in acute myocardial infarction","volume":"13","author":"Otterspoor","year":"2017","journal-title":"EuroIntervention"},{"issue":"20","key":"10.1016\/j.pharmthera.2026.108995_bb1210","doi-asserted-by":"crossref","first-page":"20655","DOI":"10.1074\/jbc.M314099200","article-title":"Cardioprotective effects of erythropoietin in the reperfused ischemic heart: A potential role for cardiac fibroblasts","volume":"279","author":"Parsa","year":"2004","journal-title":"Journal of Biological Chemistry"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.108995_bb1215","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.amjcard.2005.01.082","article-title":"Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction","volume":"95","author":"Pasceri","year":"2005","journal-title":"American Journal of Cardiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb1220","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1161\/CIR.0000000000001257","article-title":"CYP2C19 Genetic testing for oral P2Y12 inhibitor therapy: A scientific statement from the American Heart Association","volume":"150","author":"Pereira","year":"2024","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.108995_bb1225","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1093\/eurheartj\/ehs065","article-title":"Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention","volume":"33","author":"Porto","year":"2012","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb1230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2011.11.005","article-title":"Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: Results of the Erythropoietin in Myocardial Infarction Trial","volume":"163","author":"Prunier","year":"2012","journal-title":"American Heart Journal"},{"key":"10.1016\/j.pharmthera.2026.108995_bb1235","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.12659\/MSM.906815","article-title":"Intracoronary nicorandil and the prevention of the no-reflow phenomenon during primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction","volume":"24","author":"Qi","year":"2018","journal-title":"Medical Science Monitor"},{"issue":"18","key":"10.1016\/j.pharmthera.2026.108995_bb1240","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026232","article-title":"Effects of nicorandil administration on infarct size in patients with ST-segment\u2013 elevation myocardial infarction undergoing primary percutaneous coronary intervention: The CHANGE trial","volume":"11","author":"Qian","year":"2022","journal-title":"Journal of the American Heart Association"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb1245","doi-asserted-by":"crossref","first-page":"591","DOI":"10.24272\/j.issn.2095-8137.2022.487","article-title":"Large animal models of cardiac ischemia-reperfusion injury: Where are we now?","volume":"44","author":"Rahman","year":"2023","journal-title":"Zoological Research"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.108995_bb1250","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1161\/CIRCRESAHA.117.310628","article-title":"Methodological rigor in preclinical cardiovascular studies: Targets to enhance reproducibility and promote research translation","volume":"120","author":"Ramirez","year":"2017","journal-title":"Circulation Research"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.108995_bb1255","first-page":"e771","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: A report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb1260","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1055\/s-0044-1781451","article-title":"Fibrinolytic agents in thromboembolic diseases: Historical perspectives and approved indications","volume":"50","author":"Rashedi","year":"2024","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108995_bb1265","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/0022-2828(95)90016-0","article-title":"Brief, intermediate and prolonged ischemia in the isolated crystalloid perfused rat heart: Relationship between susceptibility to arrhythmias and degree of ultrastructural injury","volume":"27","author":"Ravingerova","year":"1995","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"2 51-2","key":"10.1016\/j.pharmthera.2026.108995_bb1270","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1152\/ajpheart.00767.2001","article-title":"Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion","volume":"282","author":"Reffelmann","year":"2002","journal-title":"American Journal of Physiology - Heart and Circulatory Physiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb1275","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00395-006-0615-2","article-title":"The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion","volume":"101","author":"Reffelmann","year":"2006","journal-title":"Basic Research in Cardiology"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108995_bb1280","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.amjcard.2015.06.034","article-title":"Six-year prognostic value of microvascular obstruction after reperfused ST-elevation myocardial infarction as assessed by contrast-enhanced cardiovascular magnetic resonance","volume":"116","author":"Regenfus","year":"2015","journal-title":"The American Journal of Cardiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb1285","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/ehjci\/jey101","article-title":"Intramyocardial haemorrhage and prognosis after ST-elevation myocardial infarction","volume":"20","author":"Reinstadler","year":"2019","journal-title":"European Heart Journal Cardiovascular Imaging"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb1290","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.tips.2008.02.002","article-title":"Erythropoietin: ready for prime-time cardioprotection","volume":"29","author":"Riksen","year":"2008","journal-title":"Trends in Pharmacological Sciences"},{"issue":"30","key":"10.1016\/j.pharmthera.2026.108995_bb1295","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/eht100","article-title":"Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage","volume":"34","author":"Robbers","year":"2013","journal-title":"European Heart Journal"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108995_bb1300","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/01.CIR.98.10.1006","article-title":"Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction","volume":"98","author":"Rochitte","year":"1998","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.108995_bb1305","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.jacc.2005.02.061","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II)","volume":"45","author":"Ross","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"issue":"25","key":"10.1016\/j.pharmthera.2026.108995_bb1310","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/eurheartj\/ehu054","article-title":"No post-conditioning in the human heart with thrombolysis in myocardial infarction flow 2-3 on admission","volume":"35","author":"Roubille","year":"2014","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2026.108995_bb1315","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.amjcard.2024.07.011","article-title":"Efficiency and safety of intracoronary epinephrine administration in patients with ST-elevation myocardial infarction with refractory coronary no-reflow","volume":"226","author":"Ryabov","year":"2024","journal-title":"American Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2026.108995_bb1320","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pharmthera.2016.11.006","article-title":"Pericytes, integral components of adult hematopoietic stem cell niches","volume":"171","author":"S\u00e1 da Bandeira","year":"2017","journal-title":"Pharmacology and Therapeutics"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.108995_bb1325","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.119.042816","article-title":"Impact of morphine treatment with and without metoclopramide coadministration on ticagrelor-induced platelet inhibition in acute myocardial infarction: The randomized MonAMI trial","volume":"141","author":"Saad","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb1330","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0735-1097(93)90531-5","article-title":"Coronary embolization after balloon angioplasty or thromolytic therapy: An autopsy study of 32 cases","volume":"22","author":"Saber","year":"1993","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb1335","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ccd.10070","article-title":"Visualized plaque debris as a cause of distal embolization after percutaneous coronary intervention in patient with unstable angina","volume":"55","author":"Sakai","year":"2002","journal-title":"Catheterization and Cardiovascular Interventions"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108995_bb1340","first-page":"965","article-title":"Angiography-derived and sensor-wire methods to assess coronary microvascular dysfunction in patients with acute myocardial infarction","volume":"16","author":"Scarsini","year":"2023","journal-title":"JACC: Cardiovascular Imaging"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb1345","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ccd.29793","article-title":"Pressure-controlled intermittent coronary sinus occlusion improves the vasodilatory microvascular capacity and reduces myocardial injury in patients with STEMI","volume":"99","author":"Scarsini","year":"2022","journal-title":"Catheterization and Cardiovascular Interventions"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108995_bb1350","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"du Sert","year":"2020","journal-title":"PLoS Biology"},{"issue":"24","key":"10.1016\/j.pharmthera.2026.108995_bib1623","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/eurheartj\/ehw157","article-title":"Myocardial blush and microvascular reperfusion following manual thrombectomy during percutaneous coronary intervention for ST elevation myocardial infarction: Insights from the TOTAL trial","volume":"37","author":"Sharma","year":"2016","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb1355","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0474-19.2020","article-title":"Pericyte-mediated tissue repair through PDGFR\u03b2 promotes peri-infarct astrogliosis, oligodendrogenesis, and functional recovery after acute ischemic stroke","volume":"7","author":"Shibahara","year":"2020","journal-title":"ENeuro"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb1360","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/path.4646","article-title":"Large animal models of atherosclerosis--new tools for persistent problems in cardiovascular medicine","volume":"238","author":"Shim","year":"2016","journal-title":"The Journal of Pathology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb1365","first-page":"397","article-title":"\u201cExpression of concern\u201d: publication bias for positive preclinical cardioprotection studies","volume":"119","author":"Skyschally","year":"2024","journal-title":"Basic Research in Cardiology 2024 119:3"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb1370","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s44161-023-00232-y","article-title":"Nanomedicines for cardiovascular disease","volume":"2","author":"Smith","year":"2023","journal-title":"Nature Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2026.108995_bb1375","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcpa.2020.01.003","article-title":"Targeting the main anatomopathological features in animal models of myocardial infarction","volume":"176","author":"Solanes","year":"2020","journal-title":"Journal of Comparative Pathology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108995_bb1380","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4244\/EIJV9I9A181","article-title":"Reference interval for the index of coronary microvascular resistance","volume":"9","author":"Solberg","year":"2014","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb1385","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ahj.2011.12.007","article-title":"A high loading dose of clopidogrel reduces myocardial infarct size in patients undergoing primary percutaneous coronary intervention: A magnetic resonance imaging study","volume":"163","author":"Song","year":"2012","journal-title":"American Heart Journal"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.108995_bb1390","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1136\/hrt.2010.199430","article-title":"Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction","volume":"96","author":"S\u00f6rensson","year":"2010","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb1395","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/01.MAT.0000094665.72503.3C","article-title":"Aqueous oxygen attenuation of reperfusion microvascular ischemia in a canine model of myocardial infarction","volume":"49","author":"Spears","year":"2003","journal-title":"ASAIO Journal (American Society for Artificial Internal Organs\u00a0: 1992)"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb1400","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10554-017-1221-0","article-title":"Intramyocardial dissecting hematoma in anterior wall ST elevation myocardial infarction: impact on left ventricular remodeling and prognosis","volume":"34","author":"Spinelli","year":"2018","journal-title":"International Journal of Cardiovascular Imaging"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb1405","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4244\/EIJ-D-21-00741","article-title":"A prospective, first-in-human use of the NeVa mechanical thrombectomy device for patients with acute coronary syndromes","volume":"18","author":"Spirito","year":"2022","journal-title":"EuroIntervention"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.108995_bb1410","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.jacc.2022.08.747","article-title":"Mammalian target of rapamycin inhibition in patients with ST-segment elevation myocardial infarction","volume":"80","author":"St\u00e4hli","year":"2022","journal-title":"Journal of the American College of Cardiology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108995_bb1415","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018881","article-title":"Impact of morphine treatment with and without metoclopramide coadministration on myocardial and microvascular injury in acute myocardial infarction: Insights from the randomized monami trial","volume":"10","author":"Stiermaier","year":"2021","journal-title":"Journal of the American Heart Association"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.108995_bb1420","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMoa013404","article-title":"Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction","volume":"346","author":"Stone","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"17","key":"10.1016\/j.pharmthera.2026.108995_bb1425","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1001\/jama.2012.421","article-title":"Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: The INFUSE-AMI randomized trial","volume":"307","author":"Stone","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb1430","first-page":"366","article-title":"Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction","volume":"2","author":"Stone","year":"2009","journal-title":"Circulation: Cardiovascular Interventions"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.108995_bb1435","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2026.108995_bb1440","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.biopha.2018.07.014","article-title":"Role of TLR4\/MyD88\/NF-\u03baB signaling pathway in coronary microembolization-induced myocardial injury prevented and treated with nicorandil","volume":"106","author":"Su","year":"2018","journal-title":"Biomedicine and Pharmacotherapy"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108995_bb1445","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s44161-022-00133-6","article-title":"Fat infiltration in the infarcted heart as a paradigm for ventricular arrhythmias","volume":"1","author":"Sung","year":"2022","journal-title":"Nature Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2026.108995_bb1450","doi-asserted-by":"crossref","DOI":"10.1007\/s10554-025-03580-x","article-title":"Qualitative and quantitative evaluation of microvascular obstruction with delayed enhancement cardiac computed tomography in patients with ST-segment elevation myocardial infarction","author":"Takahata","year":"2025","journal-title":"The International Journal of Cardiovascular Imaging."},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb1455","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ame2.12010","article-title":"To develop a novel animal model of myocardial infarction: A\u00a0research imperative","volume":"1","author":"Tang","year":"2018","journal-title":"Animal Models and Experimental Medicine"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.108995_bb1460","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","article-title":"Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review","volume":"72","author":"Taqueti","year":"2018","journal-title":"Journal of the American College of Cardiology"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108995_bb1465","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jacc.2005.06.054","article-title":"Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: A study performed with contrast-enhanced magnetic resonance","volume":"46","author":"Tarantini","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108995_bib1624","first-page":"531","article-title":"Out-of-hospital initiation of hypothermia in ST-segment elevation myocardial infarction: A randomised trial","volume":"105","author":"Testori","year":"2019","journal-title":"Heart (British Cardiac Society)"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb1470","first-page":"605","volume":"4","author":"Thiele","year":"2011","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb1475","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCULATIONAHA.107.747642","volume":"118","author":"Thiele","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb1480","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00000542-197609000-00016","article-title":"Sodium nitroprusside: pharmacology, toxicology and therapeutics","volume":"45","author":"Tinker","year":"1976","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb1485","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/00015385.2025.2452097","article-title":"Impact of different glycoprotein IIb\/IIIa inhibitor infusion routes on infarct size and microvascular obstruction in patients with high thrombotic risk ST elevation myocardial infarction","volume":"80","author":"Tokdil","year":"2025","journal-title":"Acta Cardiologica"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb1490","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cbf.3173","article-title":"Large animal models of cardiovascular disease","volume":"34","author":"Tsang","year":"2016","journal-title":"Cell Biochemistry and Function"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb1495","doi-asserted-by":"crossref","first-page":"C868","DOI":"10.1152\/ajpcell.00403.2025","article-title":"Pericytes in tissue fibrosis","volume":"329","author":"Tuleta","year":"2025","journal-title":"American Journal of Physiology. Cell Physiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb1500","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.4244\/EIJ-D-17-00307","article-title":"Bivalirudin infusion to reduce ventricular infarction: The openlabel, randomised Bivalirudin Infusion for Ventricular InfArction Limitation (BIVAL) study","volume":"13","author":"Van Geuns","year":"2017","journal-title":"EuroIntervention"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108995_bb1505","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jcmg.2014.05.010","article-title":"Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients","volume":"7","author":"Van Kranenburg","year":"2014","journal-title":"JACC. Cardiovascular Imaging"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108995_bb1510","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/CIRCULATIONAHA.118.035931","article-title":"Evaluation of microvascular injury in revascularized patients with ST-segment-elevation myocardial infarction treated with ticagrelor versus prasugrel: The REDUCE-MVI trial","volume":"139","author":"Van Leeuwen","year":"2019","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108995_bb1515","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12806","article-title":"Effect of adrenergic agonists on coronary blood flow: A laboratory study in healthy volunteers","volume":"4","author":"Vargas Pelaez","year":"2016","journal-title":"Physiological Reports"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.108995_bb1520","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1093\/cvr\/cvab370","article-title":"Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart","volume":"118","author":"van der Velden","year":"2022","journal-title":"Cardiovascular Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108995_bb1525","doi-asserted-by":"crossref","DOI":"10.1530\/JME-23-0076","article-title":"Erythropoietin-mediated cardioprotection in hearts subjected to ischemia reperfusion","volume":"71","author":"V\u00e9lez","year":"2023","journal-title":"Journal of Molecular Endocrinology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb1530","first-page":"110","article-title":"Association of upstream clopidogrel administration and myocardial reperfusion assessed by cardiac magnetic resonance imaging in patients with ST-elevation myocardial infarction","volume":"3","author":"de Waha","year":"2014","journal-title":"European Heart Journal: Acute Cardiovascular Care"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108995_bib1618","first-page":"795","article-title":"Microvascular obstruction and Intramyocardial hemorrhage in reperfused myocardial infarctions: Pathophysiology and clinical insights from imaging","volume":"17","author":"Vora","year":"2024","journal-title":"JACC: Cardiovascular Imaging"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108995_bb1535","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41569-024-01020-2","article-title":"Interventional thrombus modification in STEMI","volume":"21","author":"Walsh","year":"2024","journal-title":"Nature Reviews Cardiology"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108995_bb1540","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.4244\/EIJ-D-24-00989","article-title":"Coronary stent retriever-assisted thrombectomy","volume":"21","author":"Walsh","year":"2025","journal-title":"EuroIntervention"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108995_bb1545","first-page":"693","article-title":"Influence of myocardial hemorrhage on staging of reperfused myocardial infarctions with T2 cardiac magnetic\u00a0resonance imaging: insights into the dependence on infarction type with ex\u00a0vivo\u00a0validation","volume":"12","author":"Wang","year":"2019","journal-title":"JACC: Cardiovascular Imaging"},{"key":"10.1016\/j.pharmthera.2026.108995_bb1550","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jconrel.2022.11.057","article-title":"Recent advances in nanomedicines for imaging and therapy of myocardial ischemia-reperfusion injury","volume":"353","author":"Wang","year":"2023","journal-title":"Journal of Controlled Release"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108995_bb1555","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0022-2828(05)82391-0","article-title":"Endothelial cell \u2018swelling\u2019 in ischaemia and reperfusion","volume":"27","author":"Ward","year":"1995","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108995_bb1560","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/eurheartj\/ehv467","article-title":"Enhancement patterns detected by multidetector computed tomography are associated with microvascular obstruction and left ventricular remodelling in patients with acute myocardial infarction","volume":"37","author":"Watabe","year":"2016","journal-title":"European Heart Journal"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108995_bb1565","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/ccd.23179","article-title":"Effect of bivalirudin compared with unfractionated heparin plus abciximab on infarct size and myocardial recovery after primary percutaneous coronary intervention: The HORIZONS-AMI CMRI substudy","volume":"79","author":"W\u00f6hrle","year":"2012","journal-title":"Catheterization and Cardiovascular Interventions"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108995_bb1570","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078231","article-title":"Nicorandil in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: A systematic review and meta-analysis","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2026.108995_bb1575","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2147\/DDDT.S195918","article-title":"Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: A meta-analysis of randomized controlled trials","volume":"13","author":"Xu","year":"2019","journal-title":"Drug Design, Development and Therapy"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108995_bb1580","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/nm.2022","article-title":"Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery","volume":"15","author":"Yemisci","year":"2009","journal-title":"Nature Medicine"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.108995_bb1585","first-page":"1990","article-title":"Limitation of infarct size and no-reflow by intracoronary adenosine depends critically on dose and duration","volume":"8","author":"Yetgin","year":"2015","journal-title":"JACC: Cardiovascular Interventions"},{"key":"10.1016\/j.pharmthera.2026.108995_bb1590","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/bs.vh.2017.04.001","article-title":"The erythropoietin system protects the heart upon injury by cardiac progenitor cell activation","volume":"105","author":"Zafeiriou","year":"2017","journal-title":"Vitamins and Hormones"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108995_bb1595","doi-asserted-by":"crossref","DOI":"10.3390\/ph17020196","article-title":"Impact of bivalirudin on ischemia\/reperfusion injury in patients with reperfused STEMI assessed by cardiac magnetic resonance","volume":"17","author":"Zhang","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.108995_bb1600","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1073\/pnas.1922095117","article-title":"ATP- And voltage-dependent electro-metabolic signaling regulates blood flow in heart","volume":"117","author":"Zhao","year":"2020","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2026.108995_bb1605","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2025.1631407","article-title":"Pericytes in mouse heart","volume":"16","author":"Zhao","year":"2025","journal-title":"Frontiers in Physiology"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.108995_bb1610","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520967856","article-title":"Effect of nicorandil treatment adjunctive to percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis","volume":"48","author":"Zhou","year":"2020","journal-title":"Journal of International Medical Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108995_bb1615","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14294-z","article-title":"Optimization of large animal MI models; a systematic analysis of control groups from preclinical studies","volume":"7","author":"Zwetsloot","year":"2017","journal-title":"Scientific Reports"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826000227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826000227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:08:12Z","timestamp":1776434892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725826000227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":340,"alternative-id":["S0163725826000227"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.108995","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic interventions for coronary microvascular obstruction after acute myocardial infarction: Developments and challenges","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.108995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108995"}}